Search - tctmd.com

Displaying 421 - 440 of 646

Sort: Relevancy | Date

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

The UK All-comer TAVI Study

Presenter: Neil E. Moat

October 30, 2017

Presentation TCT 2017

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Presenter: Thomas Walther

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

Presentation TCT 2017

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Presenter: Martin B. Leon, Patrick T. O'Gara, Olaf Wendler

October 30, 2017

Presentation TCT 2017

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

Presenter: Robert O. Bonow, Michael J. Mack, Maurice E. Sarano

October 30, 2017

Presentation TCT 2017

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Michael J. Mack, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Presenter: Robert O. Bonow, Michael J. Mack, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Tetsuya Kaneko

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

Presenter: Martin B. Leon, Yongjian Wu, Jun Jiang

October 29, 2017

Presentation TCT 2017

Case Presentation: Severe Aortic Stenosis in a 65-Year-Old Man With COPD

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Yasser Sadek

October 29, 2017

Presentation TCT 2017

Summary and Take-home Messages

Presenter: Jeroen J. Bax, Axel Linke

October 29, 2017

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Advertisement

The PARTNER 3 Low-risk Trial

The UK All-comer TAVI Study

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

Case Presentation: Severe Aortic Stenosis in a 65-Year-Old Man With COPD

Summary and Take-home Messages

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content